14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 2nd May 2024 ALNY stock ended at $150.31. This is 0.233% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.46% from a day low at $147.29 to a day high of $153.85.
90 days $141.98 $174.48
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Dec 10, 2021 $172.97 $179.25 $172.30 $173.65 394 416
Dec 09, 2021 $177.44 $177.99 $169.90 $172.47 1 133 827
Dec 08, 2021 $181.23 $183.95 $176.47 $176.92 731 929
Dec 07, 2021 $180.11 $183.35 $176.56 $180.28 1 107 432
Dec 06, 2021 $170.00 $177.62 $169.22 $177.00 581 665
Dec 03, 2021 $183.57 $185.54 $170.25 $171.36 640 153
Dec 02, 2021 $179.43 $184.44 $178.50 $182.85 430 748
Dec 01, 2021 $183.19 $186.27 $179.64 $179.93 371 358
Nov 30, 2021 $181.53 $185.37 $179.08 $183.80 843 308
Nov 29, 2021 $189.75 $190.24 $180.38 $180.74 414 434
Nov 26, 2021 $188.80 $192.98 $185.65 $188.53 340 765
Nov 24, 2021 $187.59 $189.04 $184.01 $188.80 273 187
Nov 23, 2021 $188.00 $189.36 $180.96 $187.15 564 975
Nov 22, 2021 $188.99 $195.00 $186.02 $187.01 1 299 147
Nov 19, 2021 $174.72 $182.32 $172.57 $181.00 627 751
Nov 18, 2021 $182.29 $189.69 $178.51 $178.98 1 713 291
Nov 17, 2021 $171.70 $173.64 $167.44 $172.73 478 785
Nov 16, 2021 $172.79 $174.65 $169.78 $172.94 294 459
Nov 15, 2021 $169.74 $174.60 $169.27 $173.31 571 323
Nov 12, 2021 $174.05 $174.74 $169.90 $170.87 600 807
Nov 11, 2021 $177.24 $181.88 $172.68 $173.05 532 312
Nov 10, 2021 $183.10 $186.34 $176.01 $176.25 424 829
Nov 09, 2021 $189.00 $189.00 $181.99 $183.92 471 548
Nov 08, 2021 $188.47 $189.86 $183.28 $187.97 592 066
Nov 05, 2021 $185.88 $188.22 $181.46 $187.25 705 693
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT